It is caused by Plasmodium falciparum.

Rivulorum, which is among the nine described within this group already. As no presence of the parasite P. Falciparum was detected, this brand-new species, termed A. Rivulorum-like, is not regarded as a vector. Research is currently continuing to be able to provide more detailed info on the biology and geographical distribution of this new species. These results emphasize the important place of taxonomy for studying malaria vectors. The knowledge acquired on these vectors shall help understand better the epidemiology of the condition. Identical studies are already under way in additional parts of Africa with the long-term aim of establishing a comprehensive database that may hold information on the Anopheles vectors of malaria..Arsenic trioxide was donated for this investigation by Cephalon European countries and, since 2011, by Teva Pharmaceutical Industries. All authors vouch for the completeness and accuracy of the info and the fidelity of the analysis to the protocol. Requirements for End and Response Points The primary study end point was event-free survival at 24 months after medical diagnosis, with treatment failure defined as any of the following: no achievement of hematologic complete remission after induction therapy, no achievement of molecular complete remission after three consolidation courses, molecular relapse, hematologic relapse, or death.